<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xu YF</submitter><funding>National Science Fund for Distinguished Young Scholars</funding><funding>National Key Basic Research Program of China Grant</funding><funding>Key Research Project of the Natural Science Foundation of Beijing</funding><funding>National Natural Science Foundation of China</funding><funding>China Postdoctoral Science Foundation</funding><funding>National Institutes of Health</funding><funding>National Natural Science Foundation of China (NSFC)</funding><funding>Fundamental Research Funds of Shandong University</funding><funding>Shandong University Multidisciplinary Research and Innovation Team of Young Scholars</funding><funding>National Science Fund for Excellent Young Scholars</funding><funding>Academic promotion programme of Shandong First Medical University</funding><funding>HHS|National Institutes of Health (NIH)</funding><funding>Shandong Provincial Natural Science Foundation</funding><funding>COVID-19 Emergency Tackling Research Program of Shandong University</funding><funding>Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong)</funding><funding>Fundamental Research Fund of Shandong University</funding><funding>Natural Science Foundation of Shandong Province</funding><funding>SDU|Fundamental Research Fund of Shandong University</funding><funding>NCI NIH HHS</funding><funding>NSFC|National Science Fund for Distinguished Young Scholars (National Science Foundation for Distinguished Young Scholars)</funding><pagination>e52141</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8097337</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(5)</volume><pubmed_abstract>Tyrosine phosphorylation of secretion machinery proteins is a crucial regulatory mechanism for exocytosis. However, the participation of protein tyrosine phosphatases (PTPs) in different exocytosis stages has not been defined. Here we demonstrate that PTP-MEG2 controls multiple steps of catecholamine secretion. Biochemical and crystallographic analyses reveal key residues that govern the interaction between PTP-MEG2 and its substrate, a peptide containing the phosphorylated NSF-pY&lt;sup>83&lt;/sup> site, specify PTP-MEG2 substrate selectivity, and modulate the fusion of catecholamine-containing vesicles. Unexpectedly, delineation of PTP-MEG2 mutants along with the NSF binding interface reveals that PTP-MEG2 controls the fusion pore opening through NSF independent mechanisms. Utilizing bioinformatics search and biochemical and electrochemical screening approaches, we uncover that PTP-MEG2 regulates the opening and extension of the fusion pore by dephosphorylating the DYNAMIN2-pY&lt;sup>125&lt;/sup> and MUNC18-1-pY&lt;sup>145&lt;/sup> sites. Further structural and biochemical analyses confirmed the interaction of PTP-MEG2 with MUNC18-1-pY&lt;sup>145&lt;/sup> or DYNAMIN2-pY&lt;sup>125&lt;/sup> through a distinct structural basis compared with that of the NSF-pY&lt;sup>83&lt;/sup> site. Our studies thus provide mechanistic insights in complex exocytosis processes.</pubmed_abstract><journal>EMBO reports</journal><pubmed_title>PTP-MEG2 regulates quantal size and fusion pore opening through two distinct structural bases and substrates.</pubmed_title><pmcid>PMC8097337</pmcid><funding_grant_id>2017JQ02</funding_grant_id><funding_grant_id>2020QNQT002</funding_grant_id><funding_grant_id>81822008</funding_grant_id><funding_grant_id>82072676</funding_grant_id><funding_grant_id>ZR2017BC045</funding_grant_id><funding_grant_id>ZR2020ZD39</funding_grant_id><funding_grant_id>R01 CA069202</funding_grant_id><funding_grant_id>81773704</funding_grant_id><funding_grant_id>2018YFC1003600</funding_grant_id><funding_grant_id>2020M682190</funding_grant_id><funding_grant_id>CA69202</funding_grant_id><funding_grant_id>81825022</funding_grant_id><funding_grant_id>31701230</funding_grant_id><funding_grant_id>2020XGB02</funding_grant_id><funding_grant_id>81700473</funding_grant_id><funding_grant_id>2019QL009</funding_grant_id><funding_grant_id>Z200019</funding_grant_id><pubmed_authors>Liu CH</pubmed_authors><pubmed_authors>Cui M</pubmed_authors><pubmed_authors>Zhao WD</pubmed_authors><pubmed_authors>Wang CH</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Zhang ZY</pubmed_authors><pubmed_authors>Zhu ZL</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Yang XZ</pubmed_authors><pubmed_authors>Wang YJ</pubmed_authors><pubmed_authors>Xiao P</pubmed_authors><pubmed_authors>Ji ZL</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Li KS</pubmed_authors><pubmed_authors>Song YC</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Xu YF</pubmed_authors><pubmed_authors>Xu ZG</pubmed_authors><pubmed_authors>Yu X</pubmed_authors><pubmed_authors>Sun JP</pubmed_authors></additional><is_claimable>false</is_claimable><name>PTP-MEG2 regulates quantal size and fusion pore opening through two distinct structural bases and substrates.</name><description>Tyrosine phosphorylation of secretion machinery proteins is a crucial regulatory mechanism for exocytosis. However, the participation of protein tyrosine phosphatases (PTPs) in different exocytosis stages has not been defined. Here we demonstrate that PTP-MEG2 controls multiple steps of catecholamine secretion. Biochemical and crystallographic analyses reveal key residues that govern the interaction between PTP-MEG2 and its substrate, a peptide containing the phosphorylated NSF-pY&lt;sup>83&lt;/sup> site, specify PTP-MEG2 substrate selectivity, and modulate the fusion of catecholamine-containing vesicles. Unexpectedly, delineation of PTP-MEG2 mutants along with the NSF binding interface reveals that PTP-MEG2 controls the fusion pore opening through NSF independent mechanisms. Utilizing bioinformatics search and biochemical and electrochemical screening approaches, we uncover that PTP-MEG2 regulates the opening and extension of the fusion pore by dephosphorylating the DYNAMIN2-pY&lt;sup>125&lt;/sup> and MUNC18-1-pY&lt;sup>145&lt;/sup> sites. Further structural and biochemical analyses confirmed the interaction of PTP-MEG2 with MUNC18-1-pY&lt;sup>145&lt;/sup> or DYNAMIN2-pY&lt;sup>125&lt;/sup> through a distinct structural basis compared with that of the NSF-pY&lt;sup>83&lt;/sup> site. Our studies thus provide mechanistic insights in complex exocytosis processes.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2026-05-31T09:47:51.424Z</modification><creation>2025-02-18T23:32:21.618Z</creation></dates><accession>S-EPMC8097337</accession><cross_references><pubmed>33764618</pubmed><doi>10.15252/embr.202052141</doi></cross_references></HashMap>